Page last updated: 2024-11-06

1,1,1-trifluoro-2,4-pentanedione

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,1,1-Trifluoro-2,4-pentanedione, also known as trifluoroacetylacetone (TFA), is a colorless liquid with a pungent odor. It is a versatile building block in organic synthesis, used in the preparation of various pharmaceuticals, agrochemicals, and materials. TFA is a strong chelating agent due to the presence of two enolic hydroxyl groups, which can bind to metal ions. It is also a potent β-diketone, which can undergo enolization and tautomerization. TFA is a valuable reagent for the synthesis of heterocyclic compounds, including pyrazoles, pyrimidines, and quinolines. It is also used in the synthesis of fluorinated compounds, including pharmaceuticals and agrochemicals. TFA has been investigated for its potential biological activity, including antimicrobial, anti-inflammatory, and anticancer properties. Due to its unique chemical properties and wide applications, TFA is an extensively studied compound in various fields, including organic chemistry, inorganic chemistry, medicinal chemistry, and materials science.'

1,1,1-trifluoro-2,4-pentanedione: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID73943
CHEMBL ID106855
SCHEMBL ID15160
MeSH IDM0507115

Synonyms (52)

Synonym
acetyl trifluoroacetone
EN300-19145
2,4-pentanedione, 1,1,1-trifluoro-
trifluoroacetylacetone
nsc-9455
1,1-trifluoro-2,4-pentanedione
nsc9455
367-57-7
2, 1,1,1-trifluoro-
(trifluoroacetyl)acetone
1,1-trifluoroacetylacetone
1,1,1-trifluoro-2,4-pentanedione, 98%
CHEMBL106855
1,1,1-trifluoropentane-2,4-dione
T0434
AKOS004115271
1,1,1-trifluoroacetylacetone ,
1,1,1-trifluoro-2,4-pentanedione
trifluoro-acetylacetone
9n20a8g8sw ,
unii-9n20a8g8sw
nsc 9455
einecs 206-698-5
alpha,alpha,alpha-trifluoroacetylacetone
BP-12705
FT-0605943
SC11824
1,1,1-(trifluoroacetyl)acetone
trifluoro-2,4-pentanedione, 1,1,1-
SCHEMBL15160
J-503703
DTXSID3059896
1,1,1-trifluoro-2,4-pentadione
1,1,1-trifluoro-pentane-2,4-dione
1,1,1-trifluoro2,4-pentanedione
trifluoro-2,4-pentanedione
trifluoroacetyl acetone
1,1,1,-trifluoro pentane-2,4-dione
1,1,1,-trifluoro-2,4-pentanedione
1,1,1-trifluoro-2,4-pentane-dione
1,1,1-trifluoroacetyl acetone
cf3coh=chcoch3
F0001-1054
mfcd00000427
STL185695
AMY6757
MS-20661
CS-W016278
Q27272769
1,1,1-trifluoroacetylacetone enol form
1,1,1-trifluoro-2,4-pentanedione trifluoroacetylacetone
Z104472948
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID85248In vitro cytotoxic activity against human salivary gland tumor (HSG) cells.1999Bioorganic & medicinal chemistry letters, Nov-01, Volume: 9, Issue:21
Alpha-trifluoromethylated acyloins induce apoptosis in human oral tumor cell lines.
AID82566In vitro cytotoxic activity against human gingival fibroblasts (HGF).1999Bioorganic & medicinal chemistry letters, Nov-01, Volume: 9, Issue:21
Alpha-trifluoromethylated acyloins induce apoptosis in human oral tumor cell lines.
AID85243In vitro cytotoxic activity against human squamous cell carcinoma (HSC-2) cells.1999Bioorganic & medicinal chemistry letters, Nov-01, Volume: 9, Issue:21
Alpha-trifluoromethylated acyloins induce apoptosis in human oral tumor cell lines.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (11.11)18.7374
1990's4 (44.44)18.2507
2000's1 (11.11)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.48

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.48 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index5.14 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.48)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]